{
    "clinical_study": {
        "@rank": "1394", 
        "arm_group": [
            {
                "arm_group_label": "sumatriptan", 
                "arm_group_type": "Other", 
                "description": "Patients who underwent 6 mg sumatriptan subcutaneous one time"
            }, 
            {
                "arm_group_label": "Metoclopramide", 
                "arm_group_type": "Other", 
                "description": "Patients who underwent 20 mg Metoclopramide intravenous one time"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine which drug makes lower migraine headache"
        }, 
        "brief_title": "Effect of Metoclopramide Versus Sumatriptan for Emergency Department Treatment of Migraine Headache", 
        "completion_date": {
            "#text": "November 2010", 
            "@type": "Actual"
        }, 
        "condition": "Migraine Disorders", 
        "condition_browse": {
            "mesh_term": [
                "Headache", 
                "Migraine Disorders"
            ]
        }, 
        "detailed_description": {
            "textblock": "There are different options to manage benign headache in emergency department.The\n      investigators compared Intravenous metoclopramide with Subcutaneous sumatriptan to relieve\n      pain in emergency department."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  20-60 years old and presented with acute headache similar to previous episodes,\n\n          -  with or without phonophobia,\n\n          -  photophobia,\n\n          -  vomiting or nausea.\n\n        Exclusion Criteria:\n\n          -  fever or neck stiffness,\n\n          -  altered mental state,\n\n          -  pregnancy,\n\n          -  recent trauma or seizure (within 24 hours),\n\n          -  focal neurological abnormality on physical examination,\n\n          -  allergy to metoclopramide,\n\n          -  hypertension,\n\n          -  cardiovascular diseases.\n\n        Also if the patients had taken a triptan or ergot during the last 24 hours were excluded\n        from the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "124", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01791400", 
            "org_study_id": "ASD-1213-70"
        }, 
        "intervention": [
            {
                "arm_group_label": "Metoclopramide", 
                "description": "metoclopramide, intravenous injection,20mg, one time", 
                "intervention_name": "metoclopramide, injection,20mg, one time", 
                "intervention_type": "Drug", 
                "other_name": "plasil"
            }, 
            {
                "arm_group_label": "sumatriptan", 
                "description": "Sumatriptan, subcutaneous injection, 6 mg, one time", 
                "intervention_name": "Sumatriptan, injection, 6 mg, one time", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Metoclopramide", 
                "Sumatriptan"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Metoclopramide", 
            "Sumatriptan", 
            "migraine", 
            "headache"
        ], 
        "lastchanged_date": "February 13, 2013", 
        "link": {
            "description": "Isfahan university of medical sciences", 
            "url": "http://www.mui.ac.ir"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Isfahan", 
                    "country": "Iran, Islamic Republic of"
                }, 
                "name": "Al-zahra university hospital"
            }
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Study of Effects of Metoclopramide Versus Sumatriptan on Migraine Headache", 
        "overall_official": {
            "affiliation": "Isfahan, Isfahan, Iran, Islamic Republic of", 
            "last_name": "babak masoumi, A.Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Iran: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "November 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "determining pain in Metoclopramide versus sumatriptan groups", 
            "measure": "pain", 
            "safety_issue": "Yes", 
            "time_frame": "at one hour after prescription"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01791400"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Isfahan University of Medical Sciences", 
            "investigator_full_name": "Hamidreza Shemshaki", 
            "investigator_title": "Research Assistant", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Isfahan University of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Isfahan University of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}